MicroRNA-22 Promotes Megakaryocyte Differentiation Through Repression of Its Target,

Overview

Journal Blood Adv

Specialty Hematology

Date 2019 Jan 9

PMID 30617215

Citations 8

Authors

Cary N Weiss

Keisuke Ito

Affiliations

Soon will be listed here.

Abstract

Precise control of microRNA expression contributes to development and the establishment of tissue identity, including in proper hematopoietic commitment and differentiation, whereas aberrant expression of various microRNAs has been implicated in malignant transformation. A small number of microRNAs are upregulated in megakaryocytes, among them is microRNA-22 (miR-22). Dysregulation of miR-22 leads to various hematologic malignancies and disorders, but its role in hematopoiesis is not yet well established. Here we show that upregulation of miR-22 is a critical step in megakaryocyte differentiation. Megakaryocytic differentiation in cell lines is promoted upon overexpression of miR-22, whereas differentiation is disrupted in CRISPR/Cas9-generated miR-22 knockout cell lines, confirming that miR-22 is an essential mediator of this process. RNA-sequencing reveals that miR-22 loss results in downregulation of megakaryocyte-associated genes. Mechanistically, we identify the repressive transcription factor, GFI1, as the direct target of miR-22, and upregulation of GFI1 in the absence of miR-22 inhibits megakaryocyte differentiation. Knocking down aberrant GFI1 expression restores megakaryocytic differentiation in miR-22 knockout cells. Furthermore, we have characterized hematopoiesis in miR-22 knockout animals and confirmed that megakaryocyte differentiation is similarly impaired in vivo and upon ex vivo megakaryocyte differentiation. Consistently, repression of is incomplete in the megakaryocyte lineage in miR-22 knockout mice and is aberrantly expressed upon forced megakaryocyte differentiation in explanted bone marrow from miR-22 knockout animals. This study identifies a positive role for miR-22 in hematopoiesis, specifically in promoting megakaryocyte differentiation through repression of GFI1, a target antagonistic to this process.

Citing Articles

Network Analysis of miRNA and Cytokine Landscape in Human Hematopoiesis.

Vici A, Castelli G, Francescangeli F, Cerio A, Pelosi E, Screnci M Int J Mol Sci. 2024; 25(22).

PMID: 39596371 PMC: 11595288. DOI: 10.3390/ijms252212305.

Human erythrocytes' perplexing behaviour: erythrocytic microRNAs.

Joshi U, Jani D, George L, Highland H Mol Cell Biochem. 2024; 480(2):923-935.

PMID: 39037663 DOI: 10.1007/s11010-024-05075-0.

Clinical Significance of microRNAs in Hematologic Malignancies and Hematopoietic Stem Cell Transplantation.

Sevcikova A, Fridrichova I, Nikolaieva N, Kalinkova L, Omelka R, Martiniakova M Cancers (Basel). 2023; 15(9).

PMID: 37174123 PMC: 10177548. DOI: 10.3390/cancers15092658.

miR-486-5p and miR-22-3p Enable Megakaryocytic Differentiation of Hematopoietic Stem and Progenitor Cells without Thrombopoietin.

Kao C, Jiang J, Thompson W, Papoutsakis E Int J Mol Sci. 2022; 23(10).

PMID: 35628168 PMC: 9141330. DOI: 10.3390/ijms23105355.

The Extensive Regulation of MicroRNA in Immune Thrombocytopenia.

Zhao Y, Cui S, Wang Y, Xu R Clin Appl Thromb Hemost. 2022; 28:10760296221093595.

PMID: 35536600 PMC: 9096216. DOI: 10.1177/10760296221093595.

References

Foudi A, Kramer D, Qin J, Ye D, Behlich A, Mordecai S . Distinct, strict requirements for Gfi-1b in adult bone marrow red cell and platelet generation. J Exp Med. 2014; 211(5):909-27. PMC: 4010908. DOI: 10.1084/jem.20131065. View

Saleque S, Cameron S, Orkin S . The zinc-finger proto-oncogene Gfi-1b is essential for development of the erythroid and megakaryocytic lineages. Genes Dev. 2002; 16(3):301-6. PMC: 155332. DOI: 10.1101/gad.959102. View

Ichimura A, Ruike Y, Terasawa K, Shimizu K, Tsujimoto G . MicroRNA-34a inhibits cell proliferation by repressing mitogen-activated protein kinase kinase 1 during megakaryocytic differentiation of K562 cells. Mol Pharmacol. 2010; 77(6):1016-24. DOI: 10.1124/mol.109.063321. View

Arvey A, Larsson E, Sander C, Leslie C, Marks D . Target mRNA abundance dilutes microRNA and siRNA activity. Mol Syst Biol. 2010; 6:363. PMC: 2872614. DOI: 10.1038/msb.2010.24. View

Dabrowska M, Dybkaer K, Johnsen H, Wang B, Wabl M, Pedersen F . Loss of MicroRNA targets in the 3' untranslated region as a mechanism of retroviral insertional activation of growth factor independence 1. J Virol. 2009; 83(16):8051-61. PMC: 2715787. DOI: 10.1128/JVI.00427-09. View

Tay Y, Kats L, Salmena L, Weiss D, Tan S, Ala U . Coding-independent regulation of the tumor suppressor PTEN by competing endogenous mRNAs. Cell. 2011; 147(2):344-57. PMC: 3235920. DOI: 10.1016/j.cell.2011.09.029. View

Jin Y, Chen Z, Liu X, Zhou X . Evaluating the microRNA targeting sites by luciferase reporter gene assay. Methods Mol Biol. 2012; 936:117-27. PMC: 3646406. DOI: 10.1007/978-1-62703-083-0_10. View

Tijssen M, Ghevaert C . Transcription factors in late megakaryopoiesis and related platelet disorders. J Thromb Haemost. 2013; 11(4):593-604. PMC: 3824237. DOI: 10.1111/jth.12131. View

Lu J, Guo S, Ebert B, Zhang H, Peng X, Bosco J . MicroRNA-mediated control of cell fate in megakaryocyte-erythrocyte progenitors. Dev Cell. 2008; 14(6):843-53. PMC: 2688789. DOI: 10.1016/j.devcel.2008.03.012. View

10.

Eichhorn S, Guo H, McGeary S, Rodriguez-Mias R, Shin C, Baek D . mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues. Mol Cell. 2014; 56(1):104-15. PMC: 4292926. DOI: 10.1016/j.molcel.2014.08.028. View

11.

Klusmann J, Li Z, Bohmer K, Maroz A, Koch M, Emmrich S . miR-125b-2 is a potential oncomiR on human chromosome 21 in megakaryoblastic leukemia. Genes Dev. 2010; 24(5):478-90. PMC: 2827843. DOI: 10.1101/gad.1856210. View

12.

Boulais P, Frenette P . Making sense of hematopoietic stem cell niches. Blood. 2015; 125(17):2621-9. PMC: 4408288. DOI: 10.1182/blood-2014-09-570192. View

13.

Kozomara A, Griffiths-Jones S . miRBase: annotating high confidence microRNAs using deep sequencing data. Nucleic Acids Res. 2013; 42(Database issue):D68-73. PMC: 3965103. DOI: 10.1093/nar/gkt1181. View

14.

Saleque S, Kim J, Rooke H, Orkin S . Epigenetic regulation of hematopoietic differentiation by Gfi-1 and Gfi-1b is mediated by the cofactors CoREST and LSD1. Mol Cell. 2007; 27(4):562-72. DOI: 10.1016/j.molcel.2007.06.039. View

15.

Pinho S, Marchand T, Yang E, Wei Q, Nerlov C, Frenette P . Lineage-Biased Hematopoietic Stem Cells Are Regulated by Distinct Niches. Dev Cell. 2018; 44(5):634-641.e4. PMC: 5886750. DOI: 10.1016/j.devcel.2018.01.016. View

16.

Yamamoto R, Wilkinson A, Ooehara J, Lan X, Lai C, Nakauchi Y . Large-Scale Clonal Analysis Resolves Aging of the Mouse Hematopoietic Stem Cell Compartment. Cell Stem Cell. 2018; 22(4):600-607.e4. PMC: 5896201. DOI: 10.1016/j.stem.2018.03.013. View

17.

Bruns I, Lucas D, Pinho S, Ahmed J, Lambert M, Kunisaki Y . Megakaryocytes regulate hematopoietic stem cell quiescence through CXCL4 secretion. Nat Med. 2014; 20(11):1315-20. PMC: 4258871. DOI: 10.1038/nm.3707. View

18.

Poliseno L, Salmena L, Zhang J, Carver B, Haveman W, Pandolfi P . A coding-independent function of gene and pseudogene mRNAs regulates tumour biology. Nature. 2010; 465(7301):1033-8. PMC: 3206313. DOI: 10.1038/nature09144. View

19.

Huang D, Sherman B, Lempicki R . Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009; 4(1):44-57. DOI: 10.1038/nprot.2008.211. View

20.

Weiss C, Ito K . A Macro View of MicroRNAs: The Discovery of MicroRNAs and Their Role in Hematopoiesis and Hematologic Disease. Int Rev Cell Mol Biol. 2017; 334:99-175. PMC: 5663456. DOI: 10.1016/bs.ircmb.2017.03.007. View